Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
  • Our Work
    • Psychedelic Fundamentals
    • MAPS Public Benefit Corp
    • MDMA Therapy Training
    • Zendo Project
    • Policy & Advocacy
    • Health Equity
  • Our Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • Donate
    • Host a Party
    • Participate in Trial
    • Volunteer
    • Events
    • Resources
  • Store
    • Learning
    • Apparel
    • Accessories
    • Bookshop
    • 7 Principles
Login
  • Donate
0

News

Newsweek: Molly, Psychedelic Drug, Shows Great Promise As Mental Health Treatment, New Study Finds

Summary: “What the MDMA clearly did, is it allowed people to go into dark places where ordinarily they did not want to go,” says Bessel van der Kolk, M.D., a Principal Investigator of MAPS’ …
May 10, 2021

Yawn Together: Intro to MAPS and Harm Reduction With Sara Gael

Summary: MAPS Harm Reduction Officer Sara Gael, M.A., zeroes in on the Zendo Project’s multifaceted approach to psychedelic harm reduction, which includes “education, training, and safety tools,” …
April 29, 2021

PSYCH: Rick Doblin: On 35 Years of MAPS, Opportunities for Psychedelic Investors and the Path to Creating a Strong Industry

Summary: PSYCH of Prohibition Partners interviews MAPS Founder and Executive Director Rick Doblin, Ph.D., in honor of MAPS’ 35th anniversary. When asked what MAPS will be remembered for most, Doblin …
April 28, 2021

Rolling Stone: Jews, Christians, and Muslims Are Reclaiming Ancient Psychedelic Practices, And That Could Help With Legalization

Summary: MAPS Policy and Advocacy Counsel Ismail L. Ali, J.D., highlights the challenges of obtaining legal permission for the religious use of psychedelics in this Rolling Stone article: “The core thing …
April 23, 2021

British Medical Journal Opinion: Psychedelics for Medical Purposes: Time to Change Your Mind?

Summary: In an engaging editorial for the British Medical Journal (BMJ) Opinion, Peter Brindley, M.D., encourages “scientific skeptic[s]” to “accept and celebrate the chance to change …
March 21, 2021

Stanford Social Innovation Review: The Psychedelic Revolution in Mental Health

Summary: In the Spring 2021 edition of the Stanford Social Innovation Review, journalist Marc Gunther dives into the decades-long history of MAPS, discussing its founding in 1986 by Rick Doblin, Ph.D., …
March 21, 2021

The Guardian: California Bill Would Decriminalize Psychedelics, Paving the Way for Medical Treatment

Summary: The Guardian details the introduction of California’s psychedelic decriminalization bill by State Senator Scott Wiener, who believes that “people should not be going to jail for possessing …
February 18, 2021

Lucid News: Jade Ullmann is Bridging Together Psychedelic Communities

Summary: Lucid News contributor Colleen Newvine profiles MAPS Major Gifts Officer and Connector Jade Netanya Ullmann. This article provides a window into the life of a highly successful and iconically …
February 18, 2021

Rolling Stone: Will the Federal Government Finally Embrace the Psychedelic Revolution?

Summary: In Rolling Stone, the co-founders of DoubleBlind consider the prospect of federal drug policy changes surrounding psychedelics under President Joe Biden and a new Congress. MAPS Director of Policy …
February 16, 2021

Vogue: Could the Embrace of Psychedelics Lead to a Mental-Health Revolution?

Summary: Maya Singer of Vogue interweaves an explanation of the groundbreaking progress in the expanding psychedelic field and her personal experience with ketamine therapy via telemedicine. Singer interviews …
February 13, 2021

Nature: How Ecstasy and Psilocybin Are Shaking Up Psychiatry

Summary: Nature reports on the growing field of psychedelics, citing the increase in clinical trials involving psychedelics, decriminalization efforts in the United States, establishment of psychedelic …
January 28, 2021

Psychology Today: How to Benefit from Psychedelics Without Even Taking Them

Summary: In Psychology Today, Sarah Rose Siskind outlines the ways in which people can benefit from psychedelics without actually consuming them. One of these possible advantages, Siskind argues, is that …
January 20, 2021

Posts navigation

Newer Posts Page 1 Page 2 … Page 32 Older Posts
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
  • Our Work
    • Psychedelic Fundamentals
    • MAPS Public Benefit Corp
    • MDMA Therapy Training
    • Zendo Project
    • Health Equity
    • Policy & Advocacy
  • Our Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • Donate
    • Host a Party
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up



  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2022 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Proudly powered by WordPress. Hosted by Pressable.